Recombinant zoster vaccine vs placebo
Participants with adverse events ‐ death Clinical criteria · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine showed no clear difference in participants with adverse events ‐ deathClinical criteria compared with placebo (moderate certainty).
1 finding from 1 review
- RR 0.94 [0.84, 1.04]2 studies · 29311 participantsModerate